2Gingrich JA. Caron MG. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci, 1993 ; 16: 299.
3Lichter JB, Barr CL, Kennedy JL, et al. A hypervariable segment in the human dopamine receptor D4 gene. Hum Med Genetics, 1993; 2 :767.
4Catalano M, Nobile M, NoveUi E, et aL Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients. Biol Psychiatry,1993;34: 459.
5Nothen MM, Cichon S, Hemmer S, et al. Human dopamine D4 receptor gene: frequent occurrence ofa null allele and observation of homozygosity. HumMol Genet,1994;3: 2207.
6Petronis A, Macciardi F. Association study between the dopamine D4 receptor gene and schizophrenia. Am J Med Genet(Neuro Genet), 1995;60 : 452.
7Seeman P, Ulpian C, Chouinard G, et al. Dopamine D4 receptor variant, D4 glycine194, in Africans, but in caucasians: no association with schizophrenia. Am J Med Genet (Neuropsychiatric Genetics ), 1994;54 : 384.
8Lichter JB, Barr CL, Kennedy JL, et al. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genetics, 1993;2 : 767.
9Rubinstein M, Phillips TJ, Bunzow JR, et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell, 1997;90 :991.
10Van-Tol HHM, Bunzoe JR, Guan HC, et al. Cloing of a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine, Nature, 1991;350: 614.
4EHLICHT K, GOTZ A, BOLLINGER S, et al. Dopamine D2,D3 and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding[ J ]. J. Med. Chem. ,2009,52 ( 15 ) :4 923-4 935.
5HOBNER H, HAUBMANN C, UTZ W, et al. Conjugatedenynes as nonaromatie catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D3 subtype [ J ]. J. Med. Chem. ,2000,43 ( 4 ) :756-762.
6LAUZON N M, LAVIOLETTE S R. Dopamine D4-recep- tor modulation of cortical neuronal network activity and e- motional processing:implications for neuropsychiatric dis- orders [J].Behav. Brain Res. , 2010,208 ( 1 ) : 12-22.
7STEFAN L, HARALD H, PETER G. Synthesis and bio- logical investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtype [ J ]. Bioorg. Med. Chem. Lett. ,2006,16(11) :2 955-2 959.
8IRIS R, GOTTFR1ED S. Dopamine D4 receptor exon m polymorphism,adverse life events and personality traits in a nonclinical German adult sample[ J]. Neuropsycholoiol- ogy ,2011,63 ( 1 ) :52-58.
9LINZ S, MI-LLER J, HOBNER H, et al. Design, synthesis and dopamine D4 receptor binding activities of new N-het- eroaromatic 5/6-ring Mannich bases [ J ]. Bioorg. Med. Chem. , 2009,17 ( 13 ) :4 448-4 458.
10PRANTE O,TIETZE R, HOCKE C, et al. Synthesis, ra- diofluorination, and in vitro evaluation of pyrazolo [ 1 , 5- a] pyridine-based dopamine D4 receptor ligands: discov- ery of an inverse agonist radioligand for PET [ J 3. J. Med. Chem. ,2008,51(fi) :1 800-1 810.
